Beyond Air (XAIR) Stock Forecast, Price & News

Beyond Air (NASDAQ:XAIR) Frequently Asked Questions

Is Beyond Air a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Beyond Air in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Beyond Air stock.
View analyst ratings for Beyond Air or view top-rated stocks.

When is Beyond Air's next earnings date?

Beyond Air is scheduled to release its next quarterly earnings announcement on Thursday, June 16th 2022.
View our earnings forecast for Beyond Air.

How can I listen to Beyond Air's earnings call?

Beyond Air will be holding an earnings conference call on Thursday, June 16th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Beyond Air's earnings last quarter?

Beyond Air, Inc. (NASDAQ:XAIR) issued its quarterly earnings results on Thursday, November, 11th. The company reported ($0.36) EPS for the quarter, missing analysts' consensus estimates of ($0.28) by $0.08. During the same quarter in the prior year, the firm posted ($0.30) EPS.
View Beyond Air's earnings history.

What price target have analysts set for XAIR?

4 analysts have issued 1-year target prices for Beyond Air's shares. Their forecasts range from $13.00 to $17.00. On average, they expect Beyond Air's stock price to reach $15.25 in the next twelve months. This suggests a possible upside of 168.0% from the stock's current price.
View analysts' price targets for Beyond Air or view top-rated stocks among Wall Street analysts.

Who are Beyond Air's key executives?

Beyond Air's management team includes the following people:

• Mr. Steven Adam Lisi, CEO & Chairman (Age 51, Pay $450k)
• Mr. Amir Avniel, Co-Founder, Pres, COO & Director (Age 48, Pay $400k)
• Mr. Douglas Quinton Larson, CFO, Principal Financial Officer & Principal Accounting Officer (Age 51)
• Ms. Maria Yonkoski, Head of Investor Relations
• Mr. Adam Newman, Chief Legal Officer & Gen. Counsel
• Ms. Rebecca Van Doren, Head of Sales
• Ms. Kori-Ann Taylor, Head of Marketing
• Prof. Andrew R. Colin M.D., Chief Medical Officer & Member of Scientific Advisory Board
• Dr. Giora Davidai M.D., Chief Medical Officer
• Mr. Duncan Fatkin, Chief Commercial Officer

Who are some of Beyond Air's key competitors?

Some companies that are related to Beyond Air include Cardiovascular Systems (CSII), UFP Technologies (UFPT), Surmodics (SRDX), Orthofix Medical (OFIX), Alpha Tau Medical (DRTS), SI-BONE (SIBN), IRadimed (IRMD), MiMedx Group (MDXG), Inovio Pharmaceuticals (INO), Sight Sciences (SGHT), Nyxoah (NYXH), Anika Therapeutics (ANIK), SeaSpine (SPNE), OraSure Technologies (OSUR) and Utah Medical Products (UTMD).
View all of XAIR's competitors.

What other stocks do shareholders of Beyond Air own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Beyond Air investors own include OPKO Health (OPK), NVIDIA (NVDA), Pfizer (PFE), Axsome Therapeutics (AXSM), BioCryst Pharmaceuticals (BCRX), Enphase Energy (ENPH), General Motors (GM), Livongo Health (LVGO), Main Street Capital (MAIN) and Ollie's Bargain Outlet (OLLI).

What is Beyond Air's stock symbol?

Beyond Air trades on the NASDAQ under the ticker symbol "XAIR."

Who are Beyond Air's major shareholders?

Beyond Air's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (3.09%), BlackRock Inc. (0.89%), Renaissance Technologies LLC (0.51%), Goldman Sachs Group Inc. (0.41%), Advisor Group Holdings Inc. (0.32%) and NewEdge Advisors LLC (0.28%). Company insiders that own Beyond Air stock include Amir Avniel, Douglas Beck, Robert Carey, Ron Bentsur and Steven A Lisi.
View institutional ownership trends for Beyond Air.

Which major investors are selling Beyond Air stock?

XAIR stock was sold by a variety of institutional investors in the last quarter, including Simplex Trading LLC, Cutler Group LP, Jane Street Group LLC, GSA Capital Partners LLP, Qube Research & Technologies Ltd, Goldman Sachs Group Inc., NewEdge Advisors LLC, and Advisor Group Holdings Inc.. Company insiders that have sold Beyond Air company stock in the last year include Amir Avniel, and Ron Bentsur.
View insider buying and selling activity for Beyond Air or view top insider-selling stocks.

Which major investors are buying Beyond Air stock?

XAIR stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Kestra Advisory Services LLC, Group One Trading L.P., BlackRock Inc., Vanguard Group Inc., Charles Schwab Investment Management Inc., State Street Corp, and Meitav Dash Investments Ltd.. Company insiders that have bought Beyond Air stock in the last two years include Douglas Beck, Robert Carey, and Steven A Lisi.
View insider buying and selling activity for Beyond Air or or view top insider-buying stocks.

How do I buy shares of Beyond Air?

Shares of XAIR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Beyond Air's stock price today?

One share of XAIR stock can currently be purchased for approximately $5.69.

How much money does Beyond Air make?

Beyond Air has a market capitalization of $169.74 million and generates $870 thousand in revenue each year. The company earns $-22.88 million in net income (profit) each year or ($1.20) on an earnings per share basis.

How many employees does Beyond Air have?

Beyond Air employs 41 workers across the globe.

What is Beyond Air's official website?

The official website for Beyond Air is www.ait-pharm.com.

How can I contact Beyond Air?

Beyond Air's mailing address is 825 EAST GATE BOULEVARD SUITE 320, GARDEN CITY NY, 11530. The company can be reached via phone at (516) 665-8200.